Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?
about
Helicobacter pylori Antibody Titer and Gastric Cancer ScreeningOptimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, BrazilBeyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysisPharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-AnalysisHow antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam.Potential role of probiotics in the management of gastric ulcer.High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates.Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis.
P2860
Q26780322-6CF09B7D-8DFF-431A-A4AD-70E6D3EEC980Q33626779-8442A74F-551C-4608-A9D7-60045E4C608BQ34530327-50ABEACE-1A6E-41EA-9004-2C95A4F57C73Q35117394-39E177E2-67A9-4490-8BF5-CA73D722B8C9Q35375748-0F5011BB-AEAB-4B01-BF0A-98DF57579852Q36086382-B6E85697-553A-4E5F-A52D-3C09F920F28DQ36360817-43DE36E3-2C2E-4D24-94E6-A996853DCBA4Q37206124-155109F3-AE3A-4E92-9214-910624DF2877Q37378899-A1BDDAA3-2CC2-436A-8F3B-CC1A86BD2E45Q37724709-311ED90B-6473-4896-A08B-AAB1F13B3CAEQ38191566-776DAFDB-DE12-46AE-9DF6-0641B63D5386Q38542168-7FF1E39D-BAD1-4B30-B631-FD901BEFBD41Q38825524-B014C0EC-3D7A-489B-B159-13B726AE269CQ38848225-D77F18C6-737B-4E0A-8161-F79B950A5FFCQ40631623-22E7E219-AB65-4D37-A58E-61290D5A87F6Q51721357-A5C033C7-2CBD-4C1A-8B63-CF421909C3F0Q53689041-36F385C7-394C-4844-B70D-43A729B0039F
P2860
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary clarithromycin resista ...... on for triple therapy failure?
@en
Primary clarithromycin resista ...... on for triple therapy failure?
@nl
type
label
Primary clarithromycin resista ...... on for triple therapy failure?
@en
Primary clarithromycin resista ...... on for triple therapy failure?
@nl
prefLabel
Primary clarithromycin resista ...... on for triple therapy failure?
@en
Primary clarithromycin resista ...... on for triple therapy failure?
@nl
P2093
P2860
P356
P1476
Primary clarithromycin resista ...... on for triple therapy failure?
@en
P2093
Alfredo Di Leo
Angelo Zullo
Enzo Ierardi
Floriana Giorgio
Giuseppe Losurdo
Mariabeatrice Principi
Vincenzo De Francesco
P2860
P356
10.4291/WJGP.V4.I3.43
P577
2013-08-01T00:00:00Z